(Q46577334)

English

Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease

scientific article published on 30 June 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15990426

Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15990426

Jody Corey-Bloom

2

object named as

Jody Corey-Bloom

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15990426

1

object named as

Henry Brodaty

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

author name string

Felix C V Potocnik

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15990426

Luc Truyen

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15990426

Michael Gold

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15990426

Chandrasekhar Rao V Damaraju

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15990426

publication date

30 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15990426

Dementia and Geriatric Cognitive Disorders

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15990426

20

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15990426

2-3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15990426

120-132

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15990426

Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1159%2F000086613

21 January 2018

Treatment of dementia with neurotransmission modulation

1 reference

https://api.crossref.org/works/10.1159%2F000086613

21 January 2018

Pharmacologic treatments of dementia

1 reference

https://api.crossref.org/works/10.1159%2F000086613

21 January 2018

Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1159%2F000086613

21 January 2018

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

https://api.crossref.org/works/10.1159%2F000086613

21 January 2018

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

https://api.crossref.org/works/10.1159%2F000086613

21 January 2018

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

1 reference

https://api.crossref.org/works/10.1159%2F000086613

21 January 2018

Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1159%2F000086613

21 January 2018

Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States

1 reference

https://api.crossref.org/works/10.1159%2F000086613

21 January 2018

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1159%2F000086613

21 January 2018

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1159%2F000086613

21 January 2018

A systematic review of the associations between dose regimens and medication compliance

1 reference

https://api.crossref.org/works/10.1159%2F000086613

21 January 2018

Cognitively impaired spouses as primary caregivers for demented elderly people

1 reference

https://api.crossref.org/works/10.1159%2F000086613

21 January 2018

Identifiers

10.1159/000086613

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15990426

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15990426

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46577334&oldid=2191844052"